Article

Design and synthesis of selective, high-affinity inhibitors of human cytochrome P450 2J2.

Laboratoire de Chimie et Biochimie Pharmacologiques et Toxicologiques, UMR 8601 CNRS, Universite Paris 5 René Descartes, 45 Rue des Saints-Pères, 75270 Paris Cedex 06, France.
Bioorganic & Medicinal Chemistry Letters (Impact Factor: 2.33). 06/2006; 16(10):2777-80. DOI: 10.1016/j.bmcl.2006.02.004
Source: PubMed

ABSTRACT The active site topology, substrate specificity, and biological roles of the human cytochrome P450 CYP2J2, which is mainly expressed in the cardiovascular system, are poorly known even though recent data suggest that it could be a novel biomarker and potential target for therapy of human cancer. This paper reports a first series of high-affinity, selective CYP2J2 inhibitors that are related to terfenadine, with K(i) values as low as 160nM, that should be useful tools to determine the biological roles of CYP2J2.

0 Bookmarks
 · 
98 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: CYP2J2 enzyme is highly expressed in human tumors and carcinoma cell lines, and epoxyeicosatrienoic acids, CYP2J2-mediated metabolites, have been implicated in the pathologic development of human cancers. To identify a CYP2J2 inhibitor, 50 natural products obtained from plants were screened using astemizole as a CYP2J2 probe substrate in human liver microsomes. Of these, decursin noncompetitively inhibited CYP2J2-mediated astemizole O-demethylation and terfenadine hydroxylation activities with Ki values of 8.34 and 15.8 μM, respectively. It also showed cytotoxic effects against human hepatoma HepG2 cells in a dose-dependent manner while it did not show cytotoxicity against mouse hepatocytes. The present data suggest that decursin is a potential candidate for further evaluation for its CYP2J2 targeting anti-cancer activities. Studies are currently underway to test decursin as a potential therapeutic agent for cancer.
    Food and chemical toxicology: an international journal published for the British Industrial Biological Research Association 04/2014; · 2.99 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Metalloporphyrins effectively catalyze C-H bond functionalization, including C-O (hydroxylation), C-N (amination), and C-C bond formation (carbene insertion). Over the last 20 years, numerous papers have reported that these complexes display catalytic effi-ciency and selectivity (regioselectivity and enantioselectivity) in solution (homogeneous catalysis). Green chemistry advocates idealiza-tion and production of more efficient, selective, and preferably recyclable catalysts to develop technological processes that are increas-ingly aligned with the principles. This has encouraged investigations into processes that can heterogenize efficient metalloporphyrin (MP) catalysts. Indeed, scientists have more and more often used heterogeneous catalysis as a tool to design clean and green processes. In this context, silica and its many functionalized derivatives represent an excellent strategy to obtain inexpensive, inert, and often highly pure (depending on the preparation route) supports to immobilize catalytic species. In this review, we intend to address this issue.
    Current Organic Synthesis 04/2014; 11:67-88. · 2.44 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Cytochrome P450 2J2 (CYP2J2) is an enzyme mainly found in human extrahepatic tissues, with predominant expression in the cardiovascular system. CYP2J2 plays important roles in the metabolism of endogenous metabolites and therapeutic drugs, such as arachidonic acid, astemizole, ebastine, and terfenadine. CYP2J2 is also overexpressed in human cancer tissues and cancer cell lines and may represent a potential target for therapy of human cancers. In this study, 10 natural products obtained from plants and microorganisms were screened as potential CYP2J2 inhibitors. Among them, thelephoric acid showed strong inhibition of astemizole O-demethylation activity () in a dose-dependent manner. Evaluation of the substrate dependency of the inhibitory activity of thelephoric acid showed that it strongly inhibited CYP2J2-mediated ebastine hydroxylation () and terfenadine hydroxylation () in a substrate nondependent manner. The present data suggest that this compound might be a potential candidate for further evaluation for anticancer activity.
    Journal of Life Science. 09/2013; 23(9).

Full-text (2 Sources)

Download
33 Downloads
Available from
May 29, 2014